Companies/ImageneBio Inc

Company profile

ImageneBio Inc

NASDAQ: IMA · Healthcare · Biotechnology

PublicHQ San Diego, CA · San DiegoCIK 0001835579Reports USD

#889 of 1,418 Healthcare companies by revenue41st-percentile growth

EA Score

48D

FH 45DQ 52GM 40SS 61

v0.1 · 65/100 weight · provisional

↑ balance-sheet leverage, listing tenure · ↓ operating margin, net margin

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$45.3M

Employees

as of 2026-08-19

Market cap

$64.1M

as of 2026-08-19

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$800.0k$800.0k2025

Net income-$45.3M-$45.3M2025

Operating income-$48.5M-$48.5M2025

Total assets$153.0M$153.0M2025

Liabilities$19.8M$19.8M2025

Equity$133.1M$133.1M2025

Revenue trend

FY2021 – FY2025 · USD

$9.2M

FY21

$31.0M

FY21

$15.6M

FY22

$9.2M

FY23

$3.5M

FY25

$800.0k

FY25

$800.0k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is ImageneBio Inc’s revenue?

ImageneBio Inc booked $800.0k in FY2025 revenue, growing 0.0% year over year — about the middle of the pack among Healthcare companies we track, at a -5668.6% net margin.

Peers · Healthcare

Onconetix, Inc.24D Hyperion DeFi, Inc.35D Helix BioMedix, Inc.56C BioCorRx Inc.44D Seres Therapeutics, Inc.52D Herborium Group, Inc.36D

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Realty Income Corporation$5.7B60C Sempra$12.4B64C DexCom, Inc.$4.7B87A ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+

Key facts

CEOKristin Yarema

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, CA

ExchangeNASDAQ: IMA

Employees17

IPO date1998-02-27

Latest filings

10-Q2026-08-05 8-K2026-08-05 8-K2026-07-23 8-K2026-06-26 8-K2026-06-17 8-K2026-05-07 10-Q2026-05-07 DEF 14A2026-04-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.